Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Shenkefu capsule in chronic kidney disease
ChiCTR1900024970Phase 2Recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Shenkefu in chronic kidney disease (CKD) and primary glomerulonephritis (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoint: estimated glomerular filtration rate. Started Jun 2019; status: recruiting.
02
Drugs
Shenkefu
03
Conditions
chronic kidney disease (CKD)primary glomerulonephritis
Beyond the preview
Go deeper on ChiCTR1900024970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024970.